AKI is a condition in which the kidneys suddenly lose their ability to filter waste products from the blood. This can lead to the rapid buildup of toxins in the body, posing a serious health threat if not detected in time. A key indicator of AKI is creatinine, a substance that increases in the blood when kidney function is impaired.

The main goal is to design a biosensor that can detect and continuously monitor creatinine levels in real time. This kind of real-time monitoring could revolutionize how kidney failure is diagnosed and treated, enabling earlier intervention and more personalized care. In addition to analytical performance, teams will be evaluated based on creativity, feasibility, real-world impact, and the strength of their business case.

The UB/UPC team brings together students with backgrounds in engineering, biomedical sciences, and business. This diversity allows them to approach the challenge from multiple angles—from the technical design of the sensor to its potential integration in clinical settings. The project will culminate at the SensUs Innovation Days, where teams will present and demonstrate their biosensing solutions at Eindhoven University of Technology in front of an international jury.